Matthew S. Davids, MD, MMSc¹, Sikander Ailawadhi², Asher A. Chanan-Khan, MD³, Boyd Mudenda, MD^4*, Larysa Nogaieva, MD^5*, Iryna Kryachok, MD^6*, Ganna Usenko, MD^7*, Vladimir Ivanov, MD^8*, Olena Kyselova, MD, PhD^9*, Tetiana Perekhrestenko, MD, PhD^10*, Ivan Muzhychuk, MD^11*, Alexander Myasnikov, MD^12*, Les Lukavetsky, MD^13*, Andrei Proydakov, MD^14*, Olga Uspenskaya, MD^15*, Elena Borisenkova, MD^16*, Paula Marlton, MBBS¹⁷, Tanya Siddiqi, MD, MBBS^18*, Allison M. Winter, MD¹⁹, Tamila Lysa, MD^20*, Bulat Akhatovich Bakirov^21*, Tommy Fu, PhD^4*, Mingyu Li, PhD^4*, Mohammad Ahmad, MD^4*, Zi Chen, MD, PhD^22*, Zhiyan Liang, PhD^4*, Divya J. Mekala, PhD^4*, Olena Karpenko, MD^9*, Iurii Osipov, MD^23*, Asit De, PhD^4*, Hengbang Wang, PhD^22*, Nashat Gabrail, MD^24*, Vinod Ganju, MD^25*, Tatiana Konstantinova, MD, PhD^26*, Olga Samoilova, MD, PhD^27*, Dajun Yang, MD, PhD^4,22* and Yifan Zhai, MD, PhD^4,22

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
²Mayo Clinic, Jacksonville, FL
³Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁴Ascentage Pharma Group Inc., Rockville, MD
⁵Communal Nonprofit Enterprise, Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of Сherkasy Oblast Council, Hematology and Bone Marrow Transplantation Division with Chemotherapy Rooms, Cherkasy, Ukraine
⁶Oncohematology, National Cancer Institute, Ukraine Hemoblastoses of Division of Conservative Methods of Treatment, Kyiv, Ukraine
⁷Dnipropetrovsk Regional Hematology Center, Dnipro, Ukraine
⁸Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation
⁹Medical Center “Ok!Clinic+”, Kyiv, Ukraine
¹⁰Medical Center Named by Academician Yuriy Spizhenko (ARENSIA Exploratory Medicine Unit), Kyiv, Ukraine
¹¹SI SP Grygoriev Institute of Radiology of the NAoMS of Ukraine, Kharkiv, Ukraine
¹²Republican Hospital n.a. V.A. Baranov, St. Petersburg, Russian Federation
¹³SI “Institute of Blood Pathology and Transfusion Medicine of NAoMS of Ukraine,” Hematology Department, Lviv, Ukraine
¹⁴State Institution Komi, Krasnozatonsky, Russian Federation
¹⁵Leningrad Regional Clinical Hospital, St. Petersburg, Russian Federation
¹⁶Kaluga Regional Clinical Hospital, Kaluga, Russian Federation
¹⁷Princess Alexandria Hospital and University of Queensland, Brisbane, Australia
¹⁸City of Hope National Medical Center, Duarte, CA
¹⁹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²⁰Regional Clinical Hospital n. a. O. F. Herbachevskyi, Zhytomyr, Ukraine
²¹Bashkir State Medical University, Ufa, Russian Federation
²²Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
²³Almazov National Medical Research Center, St. Petersburg, Russian Federation
²⁴Gabrail Cancer Center, Canton, OH
²⁵PASO Medical, Frankston, Australia
²⁶Regional Clinical Hospital No 1, Ekaterinburg, Russian Federation
²⁷Nizhny Novgorod Regional Clinical Hospital named after N A Semashko, Nizhniy Novgorod, Russian Federation

Jan A. Burger, MD, PhD ¹, Neil E. Kay, MD², John N. Allan, MD³, Paul M Barr, MD⁴, Jacqueline C. Barrientos, MD, MS^5*, Carolyn Owen, MD⁶, Victoria Wang^7*, Hsin-Hui Huang, PhD^8*, Lynne Neumayr, MD^8*, Christopher Abbazio, PharmD^8*, Gabriel S. Krigsfeld, PhD^8*, Sneh Mody, MBA, PharmD^8*, Paolo Ghia, MD, PhD^9,10 and Tait D. Shanafelt, MD^11*

¹MD Anderson Cancer Center, Houston, TX
²Department of Immunology, Mayo Clinic, Rochester, MN
³Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
⁴University of Rochester, Rochester, NY
⁵Mount Sinai Comprehensive Cancer Center, Miami Beach, FL
⁶Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
⁷Dana-Farber Cancer Institute, Boston
⁸AbbVie, North Chicago, IL
⁹Università Vita-Salute San Raffaele, Milano, Italy
¹⁰IRCCS Ospedale San Raffaele, Milan, Italy
¹¹School of Medicine, Stanford University, Stanford, CA

Yuan Yao, MD, MS¹, Kari G. Rabe, MS^2*, Cristine Allmer, BS^2*, Geffen Kleinstern, PhD^3*, Nicholas J. Boddicker, PhD², Shulan Tian, PhD^4*, Laura A. Bruins^5*, Daniel R. O'Brien^4*, Aaron D. Norman, MPH^6*, Huihuang Yan, PhD^4*, Timothy G. Call, MD¹, Paul J. Hampel, MD¹, Yucai Wang, MD, PhD¹, Eli Muchtar, MD¹, Saad S. Kenderian, MD¹, Neil E. Kay, MD^1,7, Celine M. Vachon, PhD⁶, James R. Cerhan, MD, PhD², Susan L. Slager, PhD¹, Esteban Braggio, PhD⁸ and Sameer A. Parikh, MBBS¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³School of Public Health, University of Haifa, Haifa, ISR
⁴Division of Computational Biology, Mayo Clinic, Rochester, MN
⁵Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
⁶Division of Epidemiology, Mayo Clinic, Rochester, MN
⁷Department of Immunology, Mayo Clinic, Rochester, MN
⁸Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ

James T. Yoon, MD^1*, Yinglu Zhou, MS^1*, Svitlana Tyekucheva, PhD^1*, Mariia Mikhaleva, MD^1*, Stacey M. Fernandes, BS^1*, Philippe Armand, MD, PhD¹, Amy C. Bessnow, MD, MPH^1*, Jennifer L. Crombie, MD¹, David C. Fisher, MD¹, Eric D. Jacobsen, MD¹, Caron A. Jacobson, MD, MMSc¹, Austin I. Kim, MD¹, Ann S. LaCasce, MD, MMSc¹, Reid W. Merryman, MD¹, Oreofe O. Odejide, MD¹, Erin M. Parry, MD, PhD¹, David A. Qualls, MD¹, Christine E. Ryan, MD¹, Aswin Sekar, MD, PhD¹, Jacob D. Soumerai, MD², Jon E. Arnason, MD³, Matthew S. Davids, MD, MMSc¹, Jennifer R. Brown, MD, PhD¹ and Inhye E. Ahn, MD¹

¹Dana-Farber Cancer Institute, Boston, MA
²Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
³Beth Israel Deaconess Medical Center, Boston, MA

Florian Simon, MD^1*, Rudy Ligtvoet, PhD^1*, Jan-Paul Bohn^2*, Thomas Noesslinger^3*, Julia Von Tresckow, MD^4*, Ruediger Liersch^5*, Tobias Gaska, MD⁶, Kathleen Jentsch-Ullrich, MD^7*, Michael Gärtner, MD^8*, Thomas Wolff^9*, Ingo Schwaner^10*, Dominik Wolf, M.D.^11*, Christof Schneider, MD^12*, Ursula Vehling-Kaiser, MD^13*, Matthias Ritgen^14*, Christian Spoer^15*, Michael J. Eckart, MD^16*, Thomas Decker^17*, Geothy Chakupurakal, MBBS¹⁸, Björn Schöttker^19*, Jens Kisro, MD, PhD²⁰, Janina Stumpf^1*, Eugen Tausch, MD^12*, Stephan Stilgenbauer, MD¹², Karl-Anton Kreuzer^21*, Sandra Robrecht, PhD^22,23*, Anna Maria Fink, MD^22*, Moritz Fürstenau, MD^24*, Kirsten Fischer, MD^22*, Valentin Goede, MD^25*, Michael Hallek, MD^26* and Barbara F. Eichhorst, MD²⁷

¹Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany
²Department of Internal Medicine V, Division of Hematology & Oncology, Medical University of Innsbruck, Innsbruck, AUT
³Medizinische Abteilung für Hämatologie und Onkologie; Hanusch Krankenhaus, Vienna, Austria
⁴Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁵Gemeinschaftspraxis für Hämatologie und Onkologie, Clemenshospital Münster, Münster, Germany
⁶Brüderkrankenhaus St. Josef, Paderborn, DEU
⁷Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, DEU
⁸Onkologisches Ambulanzzentrum Hannover (OAZ), Hannover, Germany
⁹Oncoresearch Lerchenfeld UG, Hamburg, Germany
¹⁰Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany
¹¹Department of Medicine V, Medical University of Innsbruck, Innsbruck, Austria
¹²Department of Internal Medicine III, Division of CLL, University Hospital Ulm, Ulm, Germany
¹³Outpatient Clinic, Landshut, Germany
¹⁴Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
¹⁵MVZ Klinikum Deggendorf GmbH, Deggendorf, Germany
¹⁶Onkologische Schwerpunktpraxis Erlangen, Erlangen, Germany
¹⁷Onkologie Ravensburg, Ravensburg, DEU
¹⁸Praxis für Hämatologie und Onkologie Koblenz, Koblenz, DEU
¹⁹Hämatologisch-onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany
²⁰Lübecker Onkologische Schwerpunktpraxis, Lübeck, DEU
²¹Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Cologne, DEU
²²Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Cologne, Germany
²³German CLL Study Group, University of Cologne, Cologne, Germany
²⁴Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Koeln, Germany
²⁵St. Marienhospital Cologne, Oncogeriatric Unit, Department of Geriatric Medicine, Cologne, Germany
²⁶CECAD, Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Center for Molecular Medicine, Cologne, Germany
²⁷Department I of Internal Medicine and Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany

T C^1*, Eva Minga^2*, Georgios Karakatsoulis^2*, Elisa Albi^3*, Miguel Alcoceba^4*, David Allsup^5*, Francesca Bacchiarri, MD^6*, Sotiria Besikli-Dimou^2*, Sofia Chatzileontiadou^7*, Rosa Collado^8*, Zadie Davis^9*, Maria Dimou, MD^10*, David Donaldson^11*, Maria Efstathopoulou^12*, Sara Galimberti, MD^13*, Andrea Galitzia, MD^14*, Eva Gimeno^15*, Valerio Guarente, MD^16*, Eleftheria Hatzimichael, MD, PhD^17*, Jose-Angel Hernandez-Rivas^18*, Gloria Iacoboni, MD^19*, Iliana Konstantinou^20*, Ioannis Kotsianidis^21*, Jana Kotaskova^22*, Andreas Epameinondas Koumpis^23*, Zuzana Kubova, MD^24*, Jorge Labrador, MD^25*, Luca Laurenti, MD^26,27*, Juan Marquet, MD^28*, Stanislava Maslejova, MD^22*, Carlota Mayor-Bastida^29*, Fatima Miras^30*, Riccardo Moia, MD^31*, Almudena Navarro-Bailon^32*, Jacopo Olivieri, MD, PhD^33*, Maria Papaioannou^7*, Anna Puiggros, PhD^34*, Gian Matteo Rigolin^35*, Mattia Schipani^36*, Tereza Shokralla^37*, Martin Simkovic^38*, Antigoni Tranidou^1*, Theodoros Vassilakopoulos^10*, Andrea Visentin^39*, Candida Vitale, MD, PhD^40*, George Vrachiolias^41*, Renata Walewska, MD, PhD^42*, Lucrecia Yanez San Segundo^43,44*, Jana Zuchnicka^45*, David Graham Oscier⁴², Alessandro Gozzetti^46*, Panayiotis Panayiotidis, MD¹⁰, Francesc Bosch, MD, PhD⁴⁷, Paolo Sportoletti, BSc^16*, Blanca Espinet, PhD^34*, Gerassimos Pangalis, MD^48*, Maria Angelopoulou^10*, Tomas Papajik, MD, PhD^49*, Roberta Murru^50*, Marta Coscia, MD, PhD^40*, Antonio Cuneo, MD^51*, Gianluca Gaidano, MD, PhD³⁶, Niki Stavrogianni, MD^52*, Livio Trentin⁵³, Lukas Smolej^38*, Mark Caterwood^11*, Martin Spacek^54*, Sarka Pospisilova, Prof^55*, Michael Doubek, Prof⁵⁵, Anastasia Chatzidimitriou^2*, Kostas Stamatopoulos^2*, Paolo Ghia, MD, PhD^56,57 and Lydia Scarfo, MD^3,58

¹Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece, Thessaloniki, Greece
²Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
³Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milano, Italy
⁴Hospital Universitario de Salamanca. (HUS/IBSAL), CIBERONC, and Centro de Investigación del Cáncer (CIC/USAL, Salamanca, Spain
⁵Hull York Medical School, Hull, United Kingdom
⁶Division of Hematology, University of Siena, Siena, ITA
⁷1st Department of Internal Medicine, AHEPA University Hospital of Thessaloniki, Thessaloniki, Greece
⁸Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, ESP
⁹Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom
¹⁰Department of Hematology and Bone Marrow transplantation Unit, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
¹¹Haematology Department, Belfast City Hospital, Belfast, United Kingdom
¹²Department of Haematology Athens Medical Center-Psychikon Branch, Athens, Greece
¹³Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
¹⁴Hematology and Stem Cell Transplantation Unit, Ospedale San Francesco, Hematology and Stem Cell Transplantation Unit, Ospedale San Francesco, Nuoro, Italy
¹⁵Department of Hematology, Hospital del Mar, Barcelona, Spain
¹⁶Institute of Hematology and Center for Hemato-Oncology Research, University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy
¹⁷Department of Hematology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
¹⁸Hematology Department Infanta Leonor University Hospital, Madrid, Spain
¹⁹Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, SEATTLE, WA
²⁰Department of Haematology, University of Athens, Laikon General Hospital, Athens, Athens, Greece
²¹Department of Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
²²Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
²³Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
²⁴Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
²⁵Department of Hematology, Hospital Universitario de Burgos, Universidad Isabel I, Burgos, Spain
²⁶Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Agostino Gemelli University Hospital Foundation IRCCS, Rome, Italy
²⁷Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Roma, Università Cattolica del Sacro Cuore, Rome, Italy
²⁸Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
²⁹Haematology Department, Hospital Universitario de La Princesa, Madrid, Spain
³⁰Hematology Department Hospital Universitario 12 de Octubre, Madrid, Spain
³¹Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
³²Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca., Salamanca, Spain
³³Hematology Clinic, ASUFC, Udine, Italy
³⁴Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain
³⁵Hematology Section, St. Anna University Hospital, Ferrara, Italy
³⁶Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
³⁷1st Department of Medicine - Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
³⁸4th Department of Internal Medicine – Haematology, Faculty of Medicine in Hradec Kralove, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic
³⁹Hematology Unit, Department of Medicine, University of Padova, Padova, ITA
⁴⁰Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy
⁴¹Democritus University of Thrace, Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, Alexandroupolis, Greece
⁴²Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
⁴³University Hospital MarquéS De Valdecilla - IDIVAL, Santander, Spain
⁴⁴Department of Hematology, University Hospital Marqués de Valdecilla, Santander, Spain
⁴⁵Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
⁴⁶Division of Hematology, University of Siena, Siena, Italy
⁴⁷Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
⁴⁸Department of Haematology, Psychicon Branch, Athens Medical Center, Athens, Greece
⁴⁹Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
⁵⁰Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy
⁵¹Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
⁵²Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
⁵³Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
⁵⁴1st Department of Medicine - Haematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
⁵⁵Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
⁵⁶IRCCS Ospedale San Raffaele, Milan, Italy
⁵⁷Università Vita-Salute San Raffaele, Milano, Italy
⁵⁸Medical School, Università Vita-Salute San Raffaele, Milano, Italy

Christopher Pleyer, MD¹, Emily Tomasulo, DO^2*, Jeanine Superata, MS, CRNP^1*, Rachel Adams^3*, Xin Tian, PhD^4*, Jayson Grey^3*, Pia Nierman, RN^1*, Adrian Wiestner, MD⁵ and Clare Sun, MD⁶

¹National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Division of Hematology/Oncology, Department of Medicine, Pennsylvania Hospital, Philadelphia, PA
³National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
⁴Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
⁵Laboratory of Lymphoid Malignancies, Hematology Branch, NIH, NHLBI, Bethesda, MD
⁶National Heart, Lung, and Blood Institute, National Heart, Lung and Blood Institute, Bethesda, MD

Alberto Fresa, MD^1,2*, Idanna Innocenti, MD, PhD^3*, Annamaria Tomasso, MD^4*, Candida Vitale, MD, PhD^5*, Alessandro Sanna, MD^6*, Anna Maria Frustaci, MD^7*, Andrea Visentin, MD, PhD^8*, Azzurra Anna Romeo, MD^9*, Paolo Sportoletti^10*, Annamaria Giordano, MD^11*, Francesca Perutelli, MD^5*, Roberta Murru, MD^12*, Francesca Romana Mauro, MD^13*, Antonio Mosca, MD^14*, Francesca Morelli, MD^15*, Roberta Laureana, MD^16*, Andrea Galitzia, MD^17*, Ilaria Angeletti, MD^18*, Esmeralda Conte, MD^19*, Riccardo Moia, MD^20*, Giovanni Francesco D'Arena, MD^21*, Raffaella Pasquale, MD^22*, Francesco Autore, MD, PhD^23*, Jacopo Olivieri, MD^22*, Luca Stirparo, MD^14*, Giulia Benintende, MD^24*, Andrea Corbingi, MD^9*, Maria Ilaria Del Principe^16*, Diana Giannarelli, PhD^25*, Alessandra Tedeschi, MD^7*, Marta Coscia, MD, PhD^26,27*, Eugenio Sangiorgi, MD, PhD^28*, Dimitar G Efremov, MD, PhD²⁹ and Luca Laurenti, MD^14,30*

¹Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale", Naples, Italy
²2. Hematology Section, Deparment of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, Italy
³Department of Laboratory and Haematological Sciences, Haematology Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Sacred Heart, Roma, Italy
⁴Catholic University of Sacred Heart, Hematology Section, Department of Radiological and Hematological Sciences, Rome, Italy
⁵Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, University Hospital (A.O.U.) Città della Salute e della Scienza di Torino, Torino, Italy
⁶Hematology, Department of Oncology, AOU Careggi, Firenze, Italy
⁷Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
⁸Hematology unit, Department of Medicine, University of Padova, Padova, Italy
⁹Hematology and Stem Cell transplantation Unit, S.M. Goretti Hospital, Polo Universitario Pontino, "Sapienza”, Latina, Italy
¹⁰Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato Oncologica (CREO), University of Perugia, Perugia, Italy
¹¹Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico,  and Department of Precision and Regenerative Medicine and  Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy, Bari, Italy
¹²Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy
¹³Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
¹⁴Hematology Section, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, Italy
¹⁵Department of Hematology, University of Florence, Firenze, Italy
¹⁶Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁷Hematology and Stem Cell Transplantation Unit, Ospedale San Francesco, Hematology and Stem Cell Transplantation Unit, Ospedale San Francesco, Nuoro, Italy
¹⁸Department of Onco-hematology, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy
¹⁹Hematology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University, ROMA, ITA
²⁰Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
²¹Hematology and Stem Cell Transplantation Unit, IRCCS Centro Di Riferimento Oncologico Della Basilicata, Rionero In Vulture, PZ, ITA
²²SOC Clinica Ematologia, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy
²³Hematology Section, Department of Radiological and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
²⁴Department of Medicine 5, Haematolgy and Oncology, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), Universitatsklinkum, Erlangen, Germany
²⁵Facility of Epidemiology and Biostatistics, GSTeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
²⁶Department of Medicine and Surgery, University of Insubria, Varese, Italy
²⁷Hematology Division, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy
²⁸Genomic Medicine Section, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, Rome, Italy
²⁹Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, TS, Italy
³⁰Hematology Section, Department of Radiological and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;, Rome, Italy

Jennifer A. Woyach, MD¹, Danielle M. Brander, MD², Boyu Hu, MD³, Kerry A. Rogers, MD⁴, Zulfa Omer, MD⁵, Deborah M. Stephens, DO⁶, Andrea Sitlinger, MD^7*, Fenlai Tan^8*, Yi Chen, PhD^9*, Stephen P. Anthony, DO¹⁰, Yu Chen, MD, PhD⁹, Kewei Shang, MD^11* and John C. Byrd, MD¹²

¹The Ohio State University, Columbus, OH
²Duke University, Durham, NC
³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵Division of Hematology, University of Cincinnati, Cincinnati, OH
⁶University of North Carolina Chapel Hill, Chapel Hill, NC
⁷Duke Cancer Center, Durham, NC
⁸Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
⁹Newave Pharmaceutical Inc., Pleasanton, CA
¹⁰Newave Pharmaceutical Inc., Colbert, WA
¹¹Newave Pharmaceuticals, Pleasanton, CA
¹²Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

Alan P Skarbnik, MD¹, Alexey V. Danilov, MD, PhD², Marc Hoffmann, MD³, Farrukh T. Awan, MD⁴, Frank Scarpa^5*, Caryn Davies^5*, Todd Oakland^6*, Marina Kovach^6*, Jenna Lilyquist^6*, Veerendra Munugalavadla, PhD⁷, Alan SM Yong, MD^7*, Vikram Shetty, MD^7*, John N. Allan, MD⁸ and Jennifer A. Woyach, MD⁹

¹Novant Health Cancer Institute, Charlotte, NC
²City of Hope National Medical Center, Duarte, CA
³University of Kansas Medical Center, Kansas City, KS
⁴University of Texas Southwestern Medical Center, Dallas, TX
⁵NeoGenomics Laboratories, Fort Myers, FL
⁶ConcertAI LLC, Cambridge, MA
⁷AstraZeneca, Gaithersburg, MD
⁸Weill Cornell Medical Center, New York, NY
⁹The Ohio State University, Columbus, OH

Yuting Yan, MD^1*, Yulan Zhou^2*, Weihao Chen^3*, Jun Wang^4*, Tingyu Wang^1*, Ying Yu^5*, Yujiao Jia, MD^6*, Zhen Yu^7*, Lugui Qiu¹, Fei Li⁸ and Shuhua Yi^9*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjjn, China
⁴1. State Key Laboratory of Experimental Hematology, National Clinical Research C, Tianjin, CHN
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁸Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Nicole Lamanna, MD^1*, Jennifer R. Brown, MD, PhD², Chaitra S. Ujjani, MD³, Toby A. Eyre^4*, Beenish Manzoor^5*, Nilanjan Ghosh^6*, Lindsey Roeker, MD⁷, Matthew S. Davids, MD, MMSc², Catherine C Coombs, MD^8*, Alan P Skarbnik, MD⁹, Brian T. Hill, MD, PhD¹⁰, Hande H. Tuncer, MD², Lori A. Leslie, MD^11*, Joanna M. Rhodes, MD, MSCE^12*, Isabelle Fleury, MD, MSc¹³, Paul M Barr, MD¹⁴, Nnadozie Emechebe^5*, Nicolas Martinez-Calle^15*, Christopher E. Jensen^16*, Yun Choi^17*, Dureshahwar Jawaid^5*, Laurie K Pearson, MD¹⁸, Meghan C. Thompson, MD⁷, Steven E Marx^5*, Wendy Sinai, PharmD^19*, Frederick Lansigan, MD^20*, Bita Fakhri, MD, MPH²¹, Deborah M. Stephens, DO²², Stephen J. Schuster, MD²³, Michael Coyle^24*, Irina Pivneva, PhD^25*, Talissa Watson^25*, Annie Guerin, MSc^25* and Mazyar Shadman^3*

¹Columbia University, New York, NY
²Dana-Farber Cancer Institute, Boston, MA
³Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Churchill Hospital, Oxford University, Oxford, United Kingdom
⁵AbbVie Inc., North Chicago, IL
⁶Levine Cancer Institute, Atrium Health, Charlotte, NC
⁷CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁸University of California Irvine, Irvine, CA
⁹Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, NC
¹⁰Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
¹²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹³Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Canada
¹⁴University of Rochester, Rochester, NY
¹⁵Nottingham University Hospitals, NHS Trust, Nottingham, United Kingdom
¹⁶University of North Carolina Chapel Hill, Chapel Hill, NC
¹⁷Tufts Medical Center, Boston, MA
¹⁸University of Massachusetts, Worcester, MA
¹⁹Senior Scientific Director, AbbVie, AbbVie, North Chicago, IL
²⁰Dartmouth-Hitchcock Medical Center, Lebanon
²¹Stanford Cancer Institute, Stanford University, Stanford, CA
²²Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
²³University of Pennsylvania, Philadelphia, PA
²⁴Lowell General Hospital, Lowell, MA
²⁵Analysis Group, Inc., Montreal, QC, Canada

Billy Jebaraj, PhD^1*, Eugen Tausch, MD^1*, Deyan Y. Yosifov, PhD^2*, Christof Schneider, MD^1*, Moritz Fürstenau, MD^3*, Can Zhang, PhD^4,5*, Sandra Robrecht, PhD^6*, Caspar da Cunha-Bang, MD, PhD^7*, Mark-David Levin⁸, Philipp Bernhard Staber, MD, PhD⁹, Tamar Tadmor, MD^10*, Patrick Thornton^11*, Michael Gregor, MD^12*, Anna Maria Fink, MD^4*, Kirsten Fischer, MD^6*, Matthias Ritgen^13*, Michael Hallek, MD^6*, Arnon P. Kater, MD, PhD¹⁴, Carsten Utoft Niemann, MD, PhD^7*, Barbara F. Eichhorst, MD⁶ and Stephan Stilgenbauer, MD^1,15

¹Department of Internal Medicine III, Division of CLL, University Hospital Ulm, Ulm, Germany
²Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Baden-Württemberg, Germany
³Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Koeln, Germany
⁴Faculty of Medicine and Cologne University Hospital, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany, Cologne, Germany, Cologne, Germany
⁵German CLL Study Group, Cologne, NRW, DEU
⁶Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Cologne, Germany
⁷Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁸Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
⁹Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
¹⁰Bnai Zion, Haifa, Israel
¹¹Department of Haematology, Beaumont Hospital, RCSI, Cancer Trials Ireland, Dublin, Dublin, IRL
¹²Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Lucerne, Switzerland
¹³Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
¹⁴Dept of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹⁵Comprehensive Cancer Center Ulm, University of Ulm, Ulm, Germany

Keshu Zhou^1*, Hongyun Xing^2*, Qingliang Teng^3*, Wuping Li^4*, Yafei Wang^5*, Feng Zhu^6*, Zhengming Jin, M.D.^7*, Li Zhiming^8*, Guifang Ouyang^9*, Fang Xu^10*, Shihua Huang^11* and Jianyong Li, MD¹²

¹Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
²Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China
³Department of Hematology, Taian City Central Hospital, Taian, China
⁴Department Of Lymphoma And Hematology, Jiangxi Cancer Hospital, Nanchang, China
⁵Department Of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁶Department Of Hematology, The Affiliated Hospital of XuZhou Medical University, Xuzhou, China
⁷Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁸Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁹Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
¹⁰Department of Hematology, Mianyang Central Hospital, Mianyang, China
¹¹Department Of Hematology, Yibin Second People's Hospital, Yibin, China
¹²First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Jennifer L. Crombie, MD¹, Christine E. Ryan, MD², Yue Ren, MS^2*, Svitlana Tyekucheva, PhD^3*, Celeste Carey^1*, Aaron Zou, BA^1*, Samantha Normilus, BSN^1*, Josie Montegaard, NP^1*, Jacob D. Soumerai, MD⁴, Shruti Bhandari, MD^5*, Jon E. Arnason, MD⁶, Alvaro J Alencar, MD⁷, Austin I. Kim, MD⁸, Erin M. Parry, MD, PhD², Philippe Armand, MD, PhD², David C. Fisher, MD², Jennifer R. Brown, MD, PhD⁹ and Matthew S. Davids, MD, MMSc¹⁰

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
⁵Department of Hematology and Oncology, Northern Light Cancer Care, Brewer, ME
⁶Beth Israel Deaconess Medical Center, Boston, MA
⁷Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Newton Center, MA
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA

Anthony G Mansour, MD¹, Ying Huang, MS, MA², Aseel Alsouqi, MD^3*, Adam S Kittai, MD⁴, John C. Byrd, MD⁵, Michael R. Grever, MD³, Cecelia Miller, PhD⁶, Gerard Lozanski, MD^6*, Mollie Moran, CNP^3*, Margaret S. Lucas, PA-C^3*, Swetha Suresh, CNP^3*, Cara Grantier, CNP^3*, Corinne Hoffman, MS, NP^3*, Mark Reid, CNP^3*, Kerry A. Rogers, MD³, Seema A Bhat, MD³ and Jennifer A. Woyach, MD³

¹Department of Internal Medicine, The Ohio State University, Columbus, OH
²Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
³Division of Hematology, The Ohio State University, Columbus, OH
⁴Icahn School of Medicine at Mount Sinai, New York, NY
⁵Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
⁶Division of Pathology, The Ohio State University, Columbus, OH

Stefano Molica, MD^1*, David Allsup, MD^2* and Diana Giannarelli, PhD^3*

¹Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Hull, Italy
²Castle Hill Hospital, Cottingham, GBR
³Biostatistics Unit,, b Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy, Rome, Italy

Jan A. Burger, MD, PhD ¹, Ekaterina Kim, PhD, MS^1*, Gitanjali Jayachandran, PhD^2*, Thomas Mathew^1*, Koji Sasaki, MD¹, Yesid Alvarado Valero, MD¹, Danielle Hammond, MD¹, Fadi G. Haddad, MD¹, William G. Wierda¹ and Alessandra Ferrajoli, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Mazyar Shadman, MD, MPH^1,2, Ian W. Flinn, MD, PhD³, Moshe Y. Levy, MD^4*, Benjamin B. Freeman, MD⁵, Ben Zhang, MD^6*, John M. Burke⁷, Jennifer L. Cultrera, MD⁸, Habte A. Yimer, MD⁹, Edwin C. Kingsley, MD^10*, Charles M. Farber, MD, PhD^11*, James D'Olimpio, MD^12*, Hui Yao^13*, Adam Idoine, PhD^14*, Qi An^13* and Jeff P. Sharman, MD¹⁵

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²University of Washington, Seattle, WA
³Tennessee Oncology/OneOncology, Nashville, TN
⁴Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
⁵Summit Medical Group, Florham Park, NJ
⁶Minnesota Oncology Clinic, Burnsville, MN
⁷Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
⁸Florida Cancer Specialists & Research Institute, Leesburg, FL
⁹Texas Oncology-Tyler, US Oncology Research, Tyler, TX
¹⁰Comprehensive Cancer Centers of Nevada, Las Vegas, NV
¹¹Morristown Medical Center, Atlantic Hematology Oncology, Morristown, NJ
¹²Clinical Research Alliance, Westbury, NY
¹³BeiGene (Shanghai) Co, Ltd, Shanghai, China
¹⁴BeiGene USA, Inc, San Mateo, CA
¹⁵Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR

Tanya Siddiqi, MD, MBBS^1*, Jordan Gauthier, MD, MSc^2*, Saad S. Kenderian, MD³, Danielle M. Brander, MD⁴, Kathleen Dorritie, MD⁵, Jacob D. Soumerai, MD⁶, Peter A. Riedell, MD⁷, Nirav N. Shah, MD⁸, Rajneesh Nath, MD⁹, Charalambos Andreadis, MD, MS^10*, Daniel A. Ermann, MD¹¹, Shuo Ma, MD, PhD¹², Tatyana Feldman, MD^13*, Scott R. Solomon, MD¹⁴, Stephen J. Schuster, MD¹⁵, Sherilyn A. Tuazon, MD^16*, Serena K. Perna, MD^17*, San-San Ou, MS^16*, Neha Rane, MD^17*, Eniko Papp, PhD^16*, Yizhe Chen, PhD^17* and William G. Wierda¹⁸

¹City of Hope National Medical Center, Duarte, CA
²Fred Hutchinson Cancer Center, Seattle, WA
³Mayo Clinic, Rochester, MN
⁴Duke Cancer Institute, Durham, NC
⁵UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA
⁶Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
⁷David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁸Medical College of Wisconsin, Milwaukee, WI
⁹Banner MD Anderson Cancer Center, Scottsdale, AZ
¹⁰University of California, San Francisco, San Francisco, CA
¹¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹²Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL
¹³John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ
¹⁴Northside Hospital Cancer Institute, Atlanta, GA
¹⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁶Bristol Myers Squibb, Seattle, WA
¹⁷Bristol Myers Squibb, Princeton, NJ
¹⁸The University of Texas MD Anderson Cancer Center, Houston, TX

Lisa Blixt, MD^1,2*, Pontus Hedberg, MD, PhD^3*, Sandra Eketorp Sylvan, MD, PhD^4*, Isabela Killander Möller^5*, Hannes Lindahl^6,7*, Fredrik Kahn^8,9*, Åsa Nilsdotter-Augustinsson^10*, Mats Fredrikson^11*, Sofia Nyström^12,13*, Richard Rosenquist, MD, PhD^14,15, Peter Bergman, MD, PhD^6,16*, Christina Carlander, MD, PhD^5,17*, Soo Aleman, MD, PhD^17,18*, Anders Österborg, MD, PhD^1,19* and Lotta Hansson, MD, PhD^1,19*

¹Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
²Department of Hematology, Karolinska University Hospital, Sollentuna, Sweden
³Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SWE
⁴Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SWE
⁵Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
⁶Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden
⁷Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
⁸Department of Infectious Diseases, Skåne University Hospital, Lund, Sweden
⁹Department of Clinical Sciences Lund, Section for Infection Medicine, Lund University, Lund, SWE
¹⁰Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
¹¹Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping, Sweden
¹²Department of Clinical Immunology and Transfusion Medicine, Linköping University, Linköping, Sweden
¹³Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
¹⁴Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden
¹⁵Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
¹⁶Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
¹⁷Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
¹⁸Department of Medicine Huddinge, Division of Infectious Diseases and Dermatology, Karolinska Institutet, Stockholm, Sweden
¹⁹Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

Adam S Kittai, MD¹, Ying Huang, MS, MA², Seema A Bhat, MD², Michael R. Grever, MD², Swetha Suresh, CNP^2*, Gerard Lozanski, MD^3*, Mollie Moran, CNP^2*, Megan Nussbaum^2*, Jennifer A. Woyach, MD² and Kerry A. Rogers, MD²

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Division of Hematology, The Ohio State University, Columbus, OH
³Division of Pathology, The Ohio State University, Columbus, OH

Jennifer J. Huang, MD, PhD^1,2, Laura Samples, MD^1,2, Margie Fredericks, MSN, ARNP^2*, Stephanie Louie, RN^3*, Ramya Pulluru^2*, Christine Crider^2*, Mehrdad Shakib-Azar^2*, Neena Kennedy^2*, Vikram Raghunathan, MD^1,2*, Christina Poh, MD^1,2, Mengyang Di, MD, PhD^2,4, Stephen D. Smith, MD^1,2, Brian G. Till, MD^1,5, Ajay K. Gopal, MD^1,2, Chaitra S. Ujjani, MD^1,2, Ryan C. Lynch, MD^1,2 and Mazyar Shadman, MD, MPH^1,2

¹University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA
³Fred Hutchinson Cancer Center, Seattle
⁴Division of Hematology and Oncology, University of Washington, Seattle, WA
⁵Fred Hutchinson Cancer Center, University of Washington, Seattle, WA